These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3005552)

  • 41. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
    Felder CC; Jose PA; Axelrod J
    J Pharmacol Exp Ther; 1989 Jan; 248(1):171-5. PubMed ID: 2563286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
    Plantjé JF; Daus FJ; Hansen HA; Stoof JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?
    Boireau A; Chambry J; Dubedat P; Farges G; Carruette AM; Zundel JL; Blanchard JC
    Eur J Pharmacol; 1986 Aug; 128(1-2):93-8. PubMed ID: 2875894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
    Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
    Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
    Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD
    Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain.
    Xu SX; Yu LP; Han YR; Chen Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):104-10. PubMed ID: 2530755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. D-1 dopamine receptor stimulation elevates plasma prolactin levels.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Mar; 122(1):139-42. PubMed ID: 3007174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: modulation by cholinergic, dopamine-D1 and -D2 mechanisms.
    Friedman E; Wang HY; Butkerait P
    Neuropharmacology; 1990 Jun; 29(6):537-44. PubMed ID: 2200974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein kinase C and dopamine release--II. Effect of dopamine acting drugs in vivo.
    Giambalvo CT
    Biochem Pharmacol; 1988 Oct; 37(20):4009-17. PubMed ID: 3056415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
    Plantjé JF; Hansen HA; Daus FJ; Stoof JC
    Eur J Pharmacol; 1984 Oct; 105(1-2):73-83. PubMed ID: 6208045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro.
    Arnt J; Hyttel J
    J Neural Transm; 1986; 67(3-4):225-40. PubMed ID: 2949056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.
    Missale C; Memo M; Liberini P; Spano P
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1137-43. PubMed ID: 2458445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1985 Nov; 117(3):381-5. PubMed ID: 3878300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine receptors in the central nervous system.
    Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
    Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.